drugset / Trial / NCT01809847
Ofatumumab Induction and Maintenance in Elderly Patients With Poor Risk CLL in the Context of Allogeneic Transplantation
Phase 2
Completed
20 enrolled
Technical University Dresden
University Hospital Dresden · collabUniversity Hospital Schleswig-Holstein · collabUniversity Hospital Ulm · collabUniversity Hospital of Cologne · collab
NaSingle-groupOpen-labelTreatment
Summary
To study the safety and efficacy of anti-CD20 blockade with ofatumumab in the context of allogeneic HCT in CLL
Timeline
- Start
- 2013-03
- Primary completion
- 2015-01
- Completion
- 2015-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ofatumumab | Monoclonal antibody | 1000 mg | — |